• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点蛋白VISTA的表达在快速增殖的人类细胞和T淋巴细胞中受TGF-β1 - Smad3信号通路的差异调节。

Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 - Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes.

作者信息

Schlichtner Stephanie, Yasinska Inna M, Ruggiero Sabrina, Berger Steffen M, Aliu Nijas, Prunk Mateja, Kos Janko, Meyer N Helge, Gibbs Bernhard F, Fasler-Kan Elizaveta, Sumbayev Vadim V

机构信息

Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom.

Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, Bern, Switzerland.

出版信息

Front Med (Lausanne). 2022 Feb 10;9:790995. doi: 10.3389/fmed.2022.790995. eCollection 2022.

DOI:10.3389/fmed.2022.790995
PMID:35223897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8866318/
Abstract

Immune checkpoint proteins play crucial roles in human embryonic development but are also used by cancer cells to escape immune surveillance. These proteins and biochemical pathways associated with them form a complex machinery capable of blocking the ability of cytotoxic immune lymphoid cells to attack cancer cells and, ultimately, to fully suppress anti-tumor immunity. One of the more recently discovered immune checkpoint proteins is V-domain Ig-containing suppressor of T cell activation (VISTA), which plays a crucial role in anti-cancer immune evasion pathways. The biochemical mechanisms underlying regulation of VISTA expression remain unknown. Here, we report for the first time that VISTA expression is controlled by the transforming growth factor beta type 1 (TGF-β)-Smad3 signaling pathway. However, in T lymphocytes, we found that VISTA expression was differentially regulated by TGF-β depending on their immune profile. Taken together, our results demonstrate the differential biochemical control of VISTA expression in human T cells and various types of rapidly proliferating cells, including cancer cells, fetal cells and keratinocytes.

摘要

免疫检查点蛋白在人类胚胎发育中发挥关键作用,但癌细胞也利用它们逃避免疫监视。这些蛋白及其相关的生化途径构成了一个复杂的机制,能够阻断细胞毒性免疫淋巴细胞攻击癌细胞的能力,并最终完全抑制抗肿瘤免疫。最近发现的免疫检查点蛋白之一是含V结构域免疫球蛋白的T细胞激活抑制因子(VISTA),它在抗癌免疫逃逸途径中起关键作用。VISTA表达调控的生化机制尚不清楚。在此,我们首次报道VISTA表达受转化生长因子β1(TGF-β)-Smad3信号通路控制。然而,在T淋巴细胞中,我们发现VISTA表达受TGF-β的差异调节,这取决于它们的免疫特征。综上所述,我们的结果证明了人类T细胞以及包括癌细胞、胎儿细胞和角质形成细胞在内的各种快速增殖细胞中VISTA表达的差异生化调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/3f9cc8ee71b5/fmed-09-790995-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/f1c5895ae71d/fmed-09-790995-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/b0e66776c4f4/fmed-09-790995-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/cb5d6785ce11/fmed-09-790995-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/3f9cc8ee71b5/fmed-09-790995-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/f1c5895ae71d/fmed-09-790995-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/b0e66776c4f4/fmed-09-790995-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/cb5d6785ce11/fmed-09-790995-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0c/8866318/3f9cc8ee71b5/fmed-09-790995-g0004.jpg

相似文献

1
Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 - Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes.免疫检查点蛋白VISTA的表达在快速增殖的人类细胞和T淋巴细胞中受TGF-β1 - Smad3信号通路的差异调节。
Front Med (Lausanne). 2022 Feb 10;9:790995. doi: 10.3389/fmed.2022.790995. eCollection 2022.
2
Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development.双重沉默肿瘤内在的 VISTA 和 CTLA-4 可刺激 T 细胞介导的免疫反应并抑制 MCF7 乳腺癌的发展。
Gene. 2024 Feb 20;896:148043. doi: 10.1016/j.gene.2023.148043. Epub 2023 Nov 30.
3
T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins.T 淋巴细胞诱导源自实体恶性肿瘤的人类癌细胞分泌半乳糖凝集素-9,该分子与其他免疫检查点蛋白协同作用促进免疫抑制。
J Immunother Cancer. 2023 Jan;11(1). doi: 10.1136/jitc-2022-005714.
4
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells.转化生长因子β 型 1(TGF-β)和缺氧诱导因子 1(HIF-1)转录复合物作为人类癌症和胚胎细胞中免疫抑制蛋白半乳糖凝集素-9 表达的主要调节因子。
Aging (Albany NY). 2020 Dec 8;12(23):23478-23496. doi: 10.18632/aging.202343.
5
CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.CD71+VISTA+ 红系细胞通过 TGF-β 促进调节性 T 细胞的发育和功能。
PLoS Biol. 2018 Dec 14;16(12):e2006649. doi: 10.1371/journal.pbio.2006649. eCollection 2018 Dec.
6
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.免疫检查点调节剂 VISTA 在人乳腺癌中的表达模式及临床意义。
Front Immunol. 2020 Oct 29;11:563044. doi: 10.3389/fimmu.2020.563044. eCollection 2020.
7
Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation.巨噬细胞分化和极化调节免疫检查点蛋白 V 结构域 Ig 抑制 T 细胞活化的释放。
Front Immunol. 2022 May 11;13:837097. doi: 10.3389/fimmu.2022.837097. eCollection 2022.
8
Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models.通过阻断免疫检查点、T 细胞激活的 V 结构域免疫球蛋白抑制剂(VISTA)增强黑色素瘤和腺癌的放射治疗。
Int J Mol Sci. 2023 Sep 6;24(18):13742. doi: 10.3390/ijms241813742.
9
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer.VISTA在免疫细胞上的表达与三阴性乳腺癌患者的良好预后相关。
Front Oncol. 2021 Jan 11;10:583966. doi: 10.3389/fonc.2020.583966. eCollection 2020.
10
VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.VISTA.COMP - 一种工程化的检查点受体激动剂,能够强效抑制 T 细胞介导的免疫应答。
JCI Insight. 2017 Sep 21;2(18). doi: 10.1172/jci.insight.94308.

引用本文的文献

1
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cells.新冠病毒武汉株引发免疫逃逸机制的激活,类似于癌细胞所操控的机制。
Front Immunol. 2025 Jun 18;16:1599352. doi: 10.3389/fimmu.2025.1599352. eCollection 2025.
2
Multiplex imaging reveals novel patterns of MRTFA/B activation in the breast cancer microenvironment.多重成像揭示了乳腺癌微环境中MRTFA/B激活的新模式。
J Transl Med. 2025 May 30;23(1):599. doi: 10.1186/s12967-025-06559-3.
3
Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells.

本文引用的文献

1
Functional role of galectin-9 in directing human innate immune reactions to Gram-negative bacteria and T cell apoptosis.半乳糖凝集素-9在引导人类对革兰氏阴性菌的固有免疫反应及T细胞凋亡中的功能作用。
Int Immunopharmacol. 2021 Nov;100:108155. doi: 10.1016/j.intimp.2021.108155. Epub 2021 Sep 17.
2
Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer.调节自然杀伤细胞对癌症反应的抑制性受体和免疫检查点
Cancers (Basel). 2021 Aug 24;13(17):4263. doi: 10.3390/cancers13174263.
3
Immune checkpoint inhibitors: An emergency medicine focused review.
Twist1调控免疫检查点VISTA并促进胰腺癌细胞的增殖、迁移和进展。
J Cell Mol Med. 2025 May;29(9):e70586. doi: 10.1111/jcmm.70586.
4
Macrophages suppress CD8 + T cell cytotoxic function in triple negative breast cancer via VISTA.巨噬细胞通过VISTA抑制三阴性乳腺癌中CD8 + T细胞的细胞毒性功能。
Br J Cancer. 2025 May 2. doi: 10.1038/s41416-025-03013-5.
5
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy.实体瘤免疫治疗中新兴的新型免疫检查点抑制剂
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 11. doi: 10.1007/s00210-025-04131-w.
6
It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma.是时候关注了——半乳糖凝集素-9作为胰腺导管腺癌潜在的免疫治疗靶点。
Front Immunol. 2025 Jan 31;16:1495907. doi: 10.3389/fimmu.2025.1495907. eCollection 2025.
7
Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion.半乳糖凝集素-9,一种诱导免疫抑制、白血病细胞转化和扩增的生存促进因子。
Mol Biol Rep. 2024 Apr 25;51(1):571. doi: 10.1007/s11033-024-09563-w.
8
Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma.解析CD8、CD68和VISTA作为胰腺导管腺癌患者诊断和预后标志物的潜力。
Front Immunol. 2024 Jan 30;15:1283364. doi: 10.3389/fimmu.2024.1283364. eCollection 2024.
9
Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer.阻断 V 结构域免疫球蛋白 T 细胞活化抑制因子可重编程肿瘤相关巨噬细胞,提高 PD-1 抑制剂在胃癌中的疗效。
Clin Transl Med. 2024 Feb;14(2):e1578. doi: 10.1002/ctm2.1578.
10
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors.组合阻断癌症免疫疗法:针对新兴免疫检查点受体。
Front Immunol. 2023 Oct 19;14:1264327. doi: 10.3389/fimmu.2023.1264327. eCollection 2023.
免疫检查点抑制剂:以急诊医学为重点的综述。
Am J Emerg Med. 2021 Dec;50:335-344. doi: 10.1016/j.ajem.2021.08.038. Epub 2021 Aug 19.
4
Immune functions as a ligand or a receptor, cancer prognosis potential, clinical implication of VISTA in cancer immunotherapy.免疫功能作为配体或受体,VISTA 在癌症免疫治疗中的癌症预后潜能、临床意义。
Semin Cancer Biol. 2022 Nov;86(Pt 2):1066-1075. doi: 10.1016/j.semcancer.2021.08.008. Epub 2021 Aug 21.
5
High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells.高迁移率族蛋白 B1(HMGB1)诱导人癌细胞中 Toll 样受体 4 介导的免疫抑制蛋白半乳糖凝集素-9 的产生。
Front Immunol. 2021 Jun 21;12:675731. doi: 10.3389/fimmu.2021.675731. eCollection 2021.
6
Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma.免疫检查点调节因子IDO、VISTA、LAG3和TIM3在切除的胰腺导管腺癌中的表达
Cancers (Basel). 2021 May 29;13(11):2689. doi: 10.3390/cancers13112689.
7
Structural Basis of VSIG3: The Ligand for VISTA.VSIG3 的结构基础:VISTA 的配体。
Front Immunol. 2021 Mar 25;12:625808. doi: 10.3389/fimmu.2021.625808. eCollection 2021.
8
Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity.半乳糖凝集素-9与VISTA的配体-受体相互作用抑制人类T淋巴细胞的细胞毒性活性。
Front Immunol. 2020 Nov 20;11:580557. doi: 10.3389/fimmu.2020.580557. eCollection 2020.
9
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells.转化生长因子β 型 1(TGF-β)和缺氧诱导因子 1(HIF-1)转录复合物作为人类癌症和胚胎细胞中免疫抑制蛋白半乳糖凝集素-9 表达的主要调节因子。
Aging (Albany NY). 2020 Dec 8;12(23):23478-23496. doi: 10.18632/aging.202343.
10
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.TIM-3/galectin-9 通路及其在人乳腺癌中的调控机制。
Front Immunol. 2019 Jul 11;10:1594. doi: 10.3389/fimmu.2019.01594. eCollection 2019.